Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
162.6 USD | +0.69% | -4.07% | +4.95% |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
04-29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.95% | 288B | |
+34.00% | 704B | |
+26.73% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+15.11% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B | |
-11.01% | 145B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie's Skyrizi Secures European Union's Approval for Psoriatic Arthritis